# Charles River Laboratories International, Inc.: Form 8-K, filed Feb 25, 2026

- Company: [Charles River Laboratories International, Inc.](/companies/crl.md) (CIK 1100682)
- Form: 8-K
- Filed: 2026-02-25
- Accepted by EDGAR: Feb 25, 2026, 07:34 ET
- Period: 2026-02-25
- Accession: 0001628280-26-011395
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1100682/000162828026011395/crl-20260225.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1100682/000162828026011395/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1100682/000162828026011395/crl-20260225.htm

Filed Feb 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-011395. Last ingested by Listed: Oct 26, 2026, 16:52 ET. No prices; not investment advice.